Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. - Wikidata - awgldk - TriplyDB

Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.

Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.

http://www.wikidata.org/entity/Q43037379

about

Hepatocellular Carcinoma in The Gambia and the role of Hepatitis B and Hepatitis C.Contributions of transgenic mouse studies on the research of hepatitis B virus and hepatitis C virus-induced hepatocarcinogenesis A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinoma Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data.Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma The full-length isoform of human papillomavirus 16 E6 and its splice variant E6* bind to different sites on the procaspase 8 death effector domain.DNA methylation changes in normal liver tissues and hepatocellular carcinoma with different viral infection.Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease.Hepatocellular carcinoma in the world and the middle East.Weak association between SEN virus viremia and liver disease Low-dose intermittent interferon-alpha therapy for HCV-related liver cirrhosis after curative treatment of hepatocellular carcinoma Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma.Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma.Hepatocellular Carcinoma 11 and a Half Years after the Resolution of Chronic Hepatitis C Virus Infection Successfully Treated with Interferon Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.Frequency of and predictive factors for vascular invasion after radiofrequency ablation for hepatocellular carcinoma.Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults.Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription.Natural history of hepatitis-related hepatocellular carcinoma.Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010.Occult hepatitis B virus infection and its clinical implications.Progression from chronic hepatitis to hepatocellular carcinoma: natural course and treatments.Impact of oestrogens on the progression of liver disease.Cell cycle-related kinase is a direct androgen receptor-regulated gene that drives β-catenin/T cell factor-dependent hepatocarcinogenesis.Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies.High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis.Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy.Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients.Extrahepatic biliary obstruction after percutaneous tumour ablation for hepatocellular carcinoma: aetiology and successful treatment with endoscopic papillary balloon dilatation.Hepatitis B virus X protein enhances androgen receptor-responsive gene expression depending on androgen level.Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.The Clinicopathologic and Prognostic Significance of Gross Classification on Solitary Hepatocellular Carcinoma After Hepatectomy Relationship of α-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosis.The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area

P2860

Q24815408-AC5515DB-CBD8-41CD-B130-B3D6B27E9CAF Q26775804-7358CF64-DC5C-41CA-B808-D501E11A2901 Q27473000-FBDD69F3-1D9B-4364-A84A-D62FBF69CA67 Q27477952-E4274991-F73B-44BB-BF1B-24D2D8528128 Q30479629-83EF3C3D-3473-44A1-943E-01099AAE4E12 Q33213145-A03A0954-2653-4DBA-B11A-4254ED6DAD61 Q33373735-E71C4ADB-6863-406B-8E7D-BA708C133A0F Q33391833-309B5311-C6ED-40BA-BF75-5EFC2661B31D Q33614450-C8D8C9D9-245A-4319-B4D8-28C5A78A9721 Q33766987-9D355EA4-A1F1-43CC-A311-B8C8F4A785D3 Q33951214-DE6057A8-796A-4AC2-8FF3-4228816CB3F4 Q34098540-15842AD6-B35F-427B-9787-30DD0DF4BA76 Q34134967-42719397-6433-405A-983C-7958B9B881E2 Q34196977-6F4C91E6-68E5-4DEA-85AF-DA00156351CF Q34225588-FED1FF47-3DC5-46DF-A16F-2EF276B9059B Q34225751-0C31683F-953E-4F78-ADA4-C2B91E68DA0F Q34297798-4676B5FF-989D-4CB9-BB05-F01A0A5DABF0 Q34336505-8D08138D-42DB-435D-8D40-BDBCBBA60502 Q34459368-760CDC68-A2AE-4316-995D-351945EFA5B3 Q34512035-88165BF0-DD1D-48A2-8936-47C7F2AA063E Q34513574-743D52E7-F93B-46F0-B7C4-3E8171F6EEF5 Q34532749-9A9BCDEE-8257-4429-A032-C15B4EAADC6A Q34546701-1EFA6F6D-80E9-4BDC-A2AC-87118948E973 Q34589546-CBCED14C-9F2A-4768-A45D-01438EEA94B2 Q34684679-AE8ABD5C-0799-4AAF-A408-CFE8828C461D Q34703532-88B068EC-AA67-4B63-B48A-0EB9824974B3 Q35020896-6D15556B-03D8-47E6-BE2E-71EAB752E827 Q35086429-73CD2596-F273-4D35-A44B-4E40AD2A4D27 Q35142859-A1EADA5C-E2AD-4ACF-945E-896048C38380 Q35268414-DE15C13D-9DAB-4DC3-9A96-04736D2D40B1 Q35356183-808AAA07-BF94-4EA5-89A7-12B4D66C2329 Q35373019-1B45B1D1-49A0-4805-BAF6-1E2B4B0B1814 Q35595625-BC75FD73-9A68-4887-87E7-6157F38CBBAE Q35597216-D6C71588-B273-4424-A28B-ADF2FAB067B8 Q35597331-A073A4B5-9278-4511-9EF7-31E2A01A3D90 Q35612596-E777CB3D-CA51-486D-A3D4-0234A8CF46E4 Q36153245-0BF1A0C7-A8CE-4FD8-B3DF-76F32ED6A574 Q36195077-5E39970F-9A9E-4CB3-B229-035633C15FED Q36386685-E6900EA4-7BEF-4E72-B00F-CEF6B37BCCA5 Q36473813-E58395EC-6C51-47F9-8F45-0502D707B77D

P2860

Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.

http://www.wikidata.org/entity/Q43037379

description

1995 nî lūn-bûn

@nan

1995年の論文

@ja

1995年学术文章

@wuu

1995年学术文章

@zh

1995年学术文章

@zh-cn

1995年学术文章

@zh-hans

1995年学术文章

@zh-my

1995年学术文章

@zh-sg

1995年學術文章

@yue

1995年學術文章

@zh-hant

name

Characteristic difference of h ...... d C- viral infection in Japan.

@en

Characteristic difference of h ...... d C- viral infection in Japan.

@nl

type

label

Characteristic difference of h ...... d C- viral infection in Japan.

@en

Characteristic difference of h ...... d C- viral infection in Japan.

@nl

prefLabel

Characteristic difference of h ...... d C- viral infection in Japan.

@en

Characteristic difference of h ...... d C- viral infection in Japan.

@nl

P1433

Q43037379-736DDE6B-19E2-4710-ABC6-028B3434986F

P1476

Q43037379-9E887219-4C3B-4F37-9195-2533DB6CAC5A

P2093

Q43037379-041EE407-6669-44A5-B6EE-42538A563AC0

Q43037379-242B8CC8-FDF0-46A2-9A43-11180D510609

Q43037379-3DB02C9F-69D7-42B1-88E6-87B2A87484BE

Q43037379-63C16D94-3798-4139-89EF-944A98D7DA2D

Q43037379-71D5022E-A101-4959-8344-9D2D2BB0C338

Q43037379-A4CAAB0A-7C9D-486C-ABB5-C666DC4408A4

Q43037379-CF9FBB06-CE5D-48DC-8A74-D486B84879CB

Q43037379-DADD1A0E-9FFE-48F3-B7E0-2BBCFA0E5183

Q43037379-DD641F7C-0215-458B-A8B3-DC82E59D807B

Q43037379-FFA0EA32-C01A-41B2-A198-EED9A034DAFB

P304

Q43037379-13ED30F2-B43B-4865-BD1E-99C8C7F262F8

P31

Q43037379-3F637555-BC30-42B4-85A7-3CD565AB9E7D

P356

Q43037379-85A6F6E7-EBD2-4F83-8DAB-76EBB72B7F47

P407

Q43037379-DFDD9AD4-0162-4C49-8CCB-94877BD70608

P433

Q43037379-37A93AE7-B501-4B0D-AEDF-93EDA9646C8C

P478

Q43037379-C73FF068-D462-403D-A840-172820D9793D

P577

Q43037379-8A882475-CF19-4E05-8B57-53CEF03311F7

P698

Q43037379-88E6C69B-333E-4C22-915A-FE860E7C11C8

P356

0270-9139(95)90605-3

P1433

P1476

Characteristic difference of h ...... d C- viral infection in Japan.

@en

P2093

Imamura M

http://www.w3.org/2001/XMLSchema#string

Kanai F

http://www.w3.org/2001/XMLSchema#string

Kato N

http://www.w3.org/2001/XMLSchema#string

Ohashi M

http://www.w3.org/2001/XMLSchema#string

Okudaira T

http://www.w3.org/2001/XMLSchema#string

Shiina S

http://www.w3.org/2001/XMLSchema#string

Shiratori Y

http://www.w3.org/2001/XMLSchema#string

Teratani T

http://www.w3.org/2001/XMLSchema#string

Toda N

http://www.w3.org/2001/XMLSchema#string

Tohgo G

http://www.w3.org/2001/XMLSchema#string

P304

1027-1033

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/0270-9139(95)90605-3

http://www.w3.org/2001/XMLSchema#string

P407

P433

4 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

1995-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7557847

http://www.w3.org/2001/XMLSchema#string